GNCA DD: nice upside potential w/Low risk imo: "Institutions are Taking Positions in Genocea Biosciences, Inc. (NASDAQ:GNCA)" http://www.franklinindependent.com/institutions-are-taking-positions-in-genocea-biosciences-inc-nasdaqgnca/ Recent analyst ratings and price targets($13 to $40): http://www.sharetrading.news/2016/05/22/next-weeks-broker-price-targets-for-genocea-biosciences-inc-gnca-4/ $95m in Cash and very solid balance sheet: http://ir.genocea.com/releasedetail.cfm?ReleaseID=969398